Central Nervous System Disorders
ANAVEX contracts FORENAP Pharma for clinical trials of ANAVEX 2-73 in Alzheimers disease
Published in Surgery Litigation and Law Weekly, November 20th, 2009
Anavex Life Sciences Corp. ("ANAVEX" or the "Company") (OTCBB: AVXL) has selected FORENAP Pharma EURL ("FORENAP") as the contract research organization (CRO) for Phase I clinical trials of ANAVEX 2-73, the company's lead Alzheimer's drug candidate. FORENAP has been involved in pre-clinical and clinical research for 20 years and is renowned for its expertise in Central Nervous System (CNS) studies, including Alzheimer's disease.
"The selection of a world-class CRO is an important milestone in our product development process and it underscores our commitment to advance ANAVEX 2-73 through Phase I clinical trials," said Dr. Herve de Kergrohen, CEO of ANAVEX. "We are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- American College of Surgeons
Twenty Surgical Groups Say Senate Health Legislation Will Threaten Patient Access and Harm Quality - Cancer
Cancer Treatment Guidelines for Diverse Asian Economies Use Model Developed at Fred Hutchinson Cancer Research Center - Diarrhea
Data Presented at the International Diabetes Federation World Congress Compares JANUMET (sitagliptin/metformin HCl) to Metformin Alone as Initial Therapy - H1N1 Virus
FDA CONSUMER HEALTH INFORMATION UPDATES: Fraudulent H1N1 flu products, hearing aids, sound amplifiers, tobacco regulation, FDA's international posts, LASIK eye surgery, and - Health Insurance
Democratic Senators, Congresswoman, Small Business Owners Discuss Impact of Health Insurance Reform on Small Businesses - I-Flow Corporation
I-Flow Reports Profitable 2009 Third Quarter as Total Revenue Increased 14% to $36.7 Million - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
